查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
液体栓塞系统市场：现况分析与预测（2023-2030）
市场调查报告书
商品编码
1408723

液体栓塞系统市场：现况分析与预测（2023-2030）

Liquid Embolic System Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

由于不健康的生活方式导致全球免疫缺陷的盛行率不断增加，液体栓塞系统市场预计将稳定成长1.5%左右。 例如，根据BMC Public Health 的数据，2023 年7 月，不健康生活方式的盛行率分别为86.4% 的饮食、14.5% 的酒精、6.0% 的烟草、72.2% 的体力活动、42.3% 的萤幕时间和63.9% 的睡眠时间。 此外，根据 2021 年全国药物使用与健康调查 (NSDUH)，2020 年 12 岁及以上的人有 2,950 万人患有酒精使用障碍 (AUD)。 其他几个因素正在推动全球对液体栓塞系统的需求，包括遗传疾病的增加。 除此之外，利用先进治疗剂加速诊断测试，从而加快治疗程序并提高准确性，正在稳步推动液体栓塞系统市场的发展。 如今，公司正努力提供环保产品。 例如，Medtronic的Onyx 34L LES 6ml小瓶包装由98%可回收材料製成，使其成为环保产品。

依类型划分，市场分为液体栓塞瓶和液体栓塞预填充注射剂。 在2022年全球液体栓塞系统市场中，液体栓塞瓶细分市场占据最大份额。 该细分市场占据市场主导地位的原因是使用该产品进行大容量处理的高度可行性。 由于需要较少的储存空间而易于使用也是该细分市场的一个驱动因素。 因此，液体栓塞瓶将在2022年的刀片型市场中占据很大份额。

依适应症，市场分为脑动静脉畸形、肿瘤/脑肿瘤、脑动脉瘤等。 由于脑动静脉畸形病例和遗传异常的数量不断增加，预计在预测期内，脑动静脉畸形细分市场将占据相当大的市场份额。 例如，根据脑动脉瘤基金会的统计，约5%至10%的患者在常规检查中发现动静脉畸形，但约一半的患者由于突然出血或中风而导致动静脉畸形的存在变得明显。它成为了 因此，预计脑动静脉畸形类别在预测期内将表现出较高的复合年增长率。

依最终用户划分，市场分为医院、门诊手术中心等。 医院类别是根据医院提供的医疗保健的可及性、高素质的医疗人员的可用性、先进的医疗技术的使用以及世界各地的单位数量的多样化而按医院分类的。2022 年。 例如，根据美国医院协会2023年的数据，2022年美国共有6,129家医院，拥有919,649张临床床位和34,011,386名住院病患。 医院领域的市场竞争非常激烈，预计这种情况在可预见的未来仍将持续。 因此，2022年的市场规模将由医院产业主导。

为了更了解液态栓塞系统的市场介绍，市场包括北美（美国、加拿大、北美其他地区）、欧洲（德国、英国、法国、西班牙、义大利、欧洲其他地区）、亚太地区（中国、日本、印度、世界其他地区（亚太）和世界其他地区。 预计在预测期内，亚太地区全球液体栓塞系统市场将以高复合年增长率成长。 在预测期内，有几个因素正在推动市场成长，例如开放广泛的医疗产品、增加可及性、慢性病患者数量的增加以及医疗保健支出的多样化。 例如，根据美国国立卫生研究院的数据，2022年中国新增癌症患者数约为482万人和237万人。 此外，该地区主要医疗器材公司的存在、政府措施和特殊社区的扩散也对市场成长产生正面影响。 该地区在妇女健康检查方面取得了显着的进展和加强。 因此，从地区来看，预计亚太地区在预测期内将呈现更高的复合年增长率。

目录

第一章市场介绍

  • 市场定义
  • 主要目标
  • 利害关係人
  • 限制

第二章研究方法或假设

  • 调查过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第五章 COVID-19 对液体栓塞系统市场的影响

第六章液体栓塞系统市场收入（2020-2030）

第 7 章按类型划分的市场洞察

  • 液态栓塞瓶
  • 液态栓塞预充註註射液

第 8 章依指标划分的市场洞察

  • 脑动静脉畸形
  • 肿瘤与脑肿瘤
  • 脑动脉瘤
  • 其他

第 9 章最终使用者的市场洞察

  • 医院
  • 门诊手术中心
  • 其他

第 10 章按地区划分的市场洞察

  • 北美
    • 美国
    • 加拿大
    • 北美其他地区
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 亚太地区其他地区
  • 世界其他地区

第十一章液体栓塞系统市场动态

  • 市场驱动因素
  • 市场挑战
  • 影响分析

第十二章液体栓塞系统市场机会

第十三章液体栓塞系统市场趋势

第14章需求面与供给面分析

  • 需求方分析
  • 供给面分析

第 15 章价值链分析

第16章竞争场景

  • 竞争状况
    • 波特五力分析

第十七章公司简介

  • Medtronic
  • Terumo Corporation
  • BALT group
  • Johnson & Johnson Services, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Fluidx Medical Technology, Inc.
  • Instylla, Inc.
  • TheraTarget
  • Sirtex SIR-Spheres Pty Ltd.
  • NeuroSafe Medical Co., Ltd.

第十八章免责声明

简介目录
Product Code: UMHE212535

A liquid embolic system is a medical device used in healthcare services for the treatment of blood vessel abnormalities, including aneurysms, AVMs, tumors, etc. to prevent severe bleeding in blood vessels. These agents are available in the form of vials and injections and delivered into the vascular malformation sites using a catheter guided by X-ray imaging. Factors such as rising demand for minimally invasive procedures, rising cancer cases, and genetic disorders provide a propelling force to the liquid embolic system market. For instance, as per the Centers for Disease Control and Prevention, in the U.S., increasing age poses a high risk of developing gynecological cancers in most women. It has been estimated that each year in the U.S., about 71,500 new cases of gynecological cancers are diagnosed, including cervical, ovarian, uterine, vaginal, and vulvar cancers. Several factors, including a surge in diagnostic tests, a growing number of obese people, increasing awareness regarding chronic diseases like cancer, rising cancer screening programs, unhealthy lifestyles, and increased investments from the government, public, and private sectors in oncology departments are driving the growth of the market during the forecast period.

The Liquid Embolic System Market is expected to grow at a steady rate of around 1.5% owing to the increased prevalence of immune system deficiency globally due to unhealthy lifestyles. For instance, according to the BMC Public Health, in July 2023, the prevalence of unhealthy lifestyles was 86.4% for diet, 14.5% for alcohol, 6.0% for tobacco, 72.2% for physical activity, 42.3% for screen time, and 63.9% for sleep duration. Also, according to the 2021 National Survey on Drug Use and Health (NSDUH), 29.5 million people ages 12 and older had an Alcohol Use Disorder (AUD) in the year 2020. Several other factors, such as rising genetic disorders are leading drivers of the liquid embolic system globally. Apart from this, accelerated diagnostic tests with advanced therapeutics have resulted in faster treatment procedures and better accuracy which is also driving this market of liquid embolic system at a steady rate. These days companies are trying to deliver environment-friendly products. For instance, Medtronic's Onyx 34L LES packaging with 6 ml vials has been made with 98% recyclable content which makes it environment friendly.

Based on type, the market is segmented into liquid embolic vials and liquid embolic prefilled injectables. The liquid embolic vials segment held the maximum share in the global market of liquid embolic system market in 2022. This segment dominated the market because of the feasibility of using the product for large-volume treatments. The ease of use of using less storage space is also a propelling factor for this segment. Thus, liquid embolic vials held a significant share of the market amongst blade types in 2022.

Based on indication, the market is categorized into brain arteriovenous malformations, tumor and brain cancer, brain aneurysm, and others. The brain arteriovenous malformations segment is expected to hold a significant share of the market in the forecast period owing to rising cases of brain arteriovenous malformations and genetic abnormalities. For instance, according to the Brain Aneurysm Foundation, in about 5-10% of individuals, arteriovenous malformations are discovered during a routine examination while in approximately half of the patients, an arteriovenous malformation makes its presence known with sudden hemorrhage or stroke. Thus, the brain arteriovenous malformations category is expected to witness a higher CAGR during the forecast period.

Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals category held the highest share in the market in 2022 attributed to the ease of access to healthcare provided by hospitals, the availability of highly qualified healthcare personnel, the utilization of advanced medical technology, and a diverse number of units all over the globe. For instance, according to the American Hospital Association in 2023, there are in total of 6,129 hospitals in the U.S with 919,649 staffed beds and 34,011,386 hospital admissions in the year 2022. The market for the hospital segment is highly competitive and is projected to remain so in the foreseeable future. Thus, the hospital segment held dominance in the market in the year 2022.

For a better understanding of the market adoption of liquid embolic system, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow with a high CAGR in the global liquid embolic system market in the forecast period. Several factors such as the development of a wide range of medical products, enhanced accessibility, increasing cases of chronic diseases, and diversified healthcare costs are driving the market's growth during the forecast period. For instance, according to the National Institute of Health in 2022, there were approximately 4,820,000 and 2,370,000 new cancer cases in China. Further, the presence of key medical device companies in the region, and the surge in government initiatives and special communities are also having a positive impact on the market's growth. There have been significant improvisations and enhancements in women's health diagnostics in the region. Thus, amongst regions, APAC is expected to witness higher CAGR during the forecast period.

Some of the major players operating in the market include: Medtronic; Terumo Corporation; BALT group; Johnson & Johnson Services, Inc.; Meril Life Sciences Pvt. Ltd.; Fluidx Medical Technology, Inc.; Instylla, Inc.; TheraTarget; Sirtex SIR-Spheres Pty Ltd.; NeuroSafe Medical Co., Ltd.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Liquid Embolic System Market
  • 2.2. Research Methodology of the Liquid Embolic System Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE LIQUID EMBOLIC SYSTEM MARKET

6 LIQUID EMBOLIC SYSTEM MARKET REVENUE (USD BN), 2020-2030F

7 MARKET INSIGHTS BY TYPE

  • 7.1. Liquid Embolic Vials
  • 7.2. Liquid Embolic Prefilled Injectables

8 MARKET INSIGHTS BY INDICATION

  • 8.1. Brain Arteriovenous Malformations
  • 8.2. Tumor and Brain Cancer
  • 8.3. Brain Aneurysm
  • 8.4. Others

9 MARKET INSIGHTS BY END USER

  • 9.1. Hospitals
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4. Rest of World

11 LIQUID EMBOLIC SYSTEM MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 LIQUID EMBOLIC SYSTEM MARKET OPPORTUNITIES

13 LIQUID EMBOLIC SYSTEM MARKET TRENDS

14 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1. Porters Fiver Forces Analysis

17 COMPANY PROFILED

  • 17.1. Medtronic
  • 17.2. Terumo Corporation
  • 17.3. BALT group
  • 17.4. Johnson & Johnson Services, Inc.
  • 17.5. Meril Life Sciences Pvt. Ltd.
  • 17.6. Fluidx Medical Technology, Inc.
  • 17.7. Instylla, Inc.
  • 17.8. TheraTarget
  • 17.9. Sirtex SIR-Spheres Pty Ltd.
  • 17.10. NeuroSafe Medical Co., Ltd.

18 DISCLAIMER